Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 11Recruiting 8Terminated 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1

Conditions

Venous Thromboembolism 2Venous Thrombosis 1Pulmonary Embolism 1Multiple Myeloma 1

Interventions

Dalteparin 5Tinzaparin 4apixaban 2abelacimab 2Nadroparin 2MAA868 2Heparin, Low-Molecular-Weight 2Enoxaparin 2reviparin 1certoparin 1bemiparin 1acarboxyprothrombin 1Warfarin 1Rivaroxaban 1Platelet Transfusion 1Phenprocoumon 1Mass Screening 1Hematologic Tests 1Aspirin 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Venous Thromboembolism × apixaban × Clear all
NCT05171049 2026-02-23

ASTER

Anthos Therapeutics, Inc.

Phase 3 Terminated
1,150 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT04106700 2021-02-15

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Instituto de Investigacion Sanitaria La Fe

Phase 2 Terminated
60 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡